About the speaker
Professor Jane Armitage
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
11
presentations
5
followers
8 more presentations in this session
HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy
Speaker: Professor M. Fontana (London, GB)
Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control
Speaker: Professor J. Silvain (Paris, FR)
Access the full session
About the event
